Status:
UNKNOWN
Cardiac Output in Preeclamptic
Lead Sponsor:
Mansoura University
Conditions:
Echocardiography
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
There is high incidence of hypertensive disorders during pregnancy.The maternal cardiovascular system had significant changes during pregnancy. The colloid oncotic pressure is decreased during preecla...
Detailed Description
Transthoracic echocardiography considered an accurate non-invasive device and has validity for measuring cardiac functions in pregnancy.
Eligibility Criteria
Inclusion
- Pre-eclampsia
- Age 18-45 years.
- Singleton pregnancy scheduled for elective CS delivery under spinal anesthesia.
- American Society of Anesthesiologists (ASA Ⅱ, Ⅲ).
Exclusion
- Body mass index \< 18 or ≥40 kg/m²
- Women presenting in labor
- Current administration of vasoactive drugs including salbutamol and thyroxin.
- Diabetes mellitus.
- Hemoglobin \<10 g/dl.
- Cardiovascular, cerebrovascular, or renal disease
- Increased serum creatinine level ≥1.1 mg/dL.
- Contraindications to spinal anesthesia:(increased intracranial pressure, coagulopathy, or local skin infection)
Key Trial Info
Start Date :
August 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05435573
Start Date
August 17 2022
End Date
March 1 2024
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University-Emergency hospital-ICU
Al Mansurah, Egypt, 35511